Investigate the aromatherapy with damask rose extracts to reduce apnea in premature infants hospitalized in NICU ward of selected training hospitals of Esfahan in 2015
Not Applicable
- Conditions
- Apnea.Other diseases of the respiratory system
- Registration Number
- IRCT2015121925601N4
- Lead Sponsor
- Vice chancellor for research, Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
infants between 29-33 weeks gestational age; birth weight between 900-1500 grams; The baby's blood hemoglobin level higher than 10g /dl;infants Parental consent; Lack of oxygen uptake through cpAP; no need for infant ventilator; lack of heart disease or any infection.
Exclusion criteria were: discharge or death of an infant before the end of the intervention period; the incidence of respiratory symptoms and skin allergy during the study.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Heart rate. Timepoint: 24 hours after birth, and 9, 12, 15, 18 hours after the first 24 hours. Method of measurement: By monitoring device.;Arterial blood oxygen saturation percent. Timepoint: 24 hours after birth, and 9, 12, 15, 18 hours after the first 24 hours. Method of measurement: By monitoring device.;The number of episodes of apnea. Timepoint: 24 hours after birth, and 9, 12, 15, 18 hours after the first 24 hours. Method of measurement: By direct observation.
- Secondary Outcome Measures
Name Time Method